INTECH Investment Management’s Avadel Pharmaceuticals AVDL Stock Holding History

INTECH Investment Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,474	Closed	-$764K	–	2114
2025 Q4	$764K	Sell	35,474 -6,548	-16%	-$127K	0.01%	1275
2025 Q3	$642K	Sell	42,022 -16,444	-28%	-$214K	0.01%	1438
2025 Q2	$517K	Sell	58,466 -7,824	-12%	-$68.7K	﹤0.01%	1597
2025 Q1	$519K	Buy	66,290 +7,532	+13%	+$63.1K	0.01%	1595
2024 Q4	$618K	Buy	58,758 +42,418	+260%	+$515K	0.01%	1432
2024 Q3	$214K	Buy	+16,340	New	+$249K	﹤0.01%	1687

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

INTECH Investment Management's AVDL Position: Q1 2026 in Review

INTECH Investment Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 35,474 shares — an estimated $764K sold.

INTECH Investment Management first reported a position in AVDL in Q3 2024 and held it in 6 quarters. The position peaked at $764K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

INTECH Investment Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
INTECH Investment Management sold 35,474 Avadel Pharmaceuticals shares in Q1 2026, an estimated $764K.
INTECH Investment Management first reported a position in Avadel Pharmaceuticals in Q3 2024 and held it in 6 quarters.
INTECH Investment Management's Avadel Pharmaceuticals position peaked at $764K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.